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Cluster analysisa b s t r a c t
Objectives: To automatically identify and cluster clinical trials with similar eligibility features.
Methods: Using the public repository ClinicalTrials.gov as the data source, we extracted semantic features
from the eligibility criteria text of all clinical trials and constructed a trial-feature matrix. We calculated
the pairwise similarities for all clinical trials based on their eligibility features. For all trials, by selecting
one trial as the center each time, we identiﬁed trials whose similarities to the central trial were greater
than or equal to a predeﬁned threshold and constructed center-based clusters. Then we identiﬁed unique
trial sets with distinctive trial membership compositions from center-based clusters by disregarding their
structural information.
Results: From the 145,745 clinical trials on ClinicalTrials.gov, we extracted 5,508,491 semantic features.
Of these, 459,936 were unique and 160,951 were shared by at least one pair of trials. Crowdsourcing the
cluster evaluation using Amazon Mechanical Turk (MTurk), we identiﬁed the optimal similarity thresh-
old, 0.9. Using this threshold, we generated 8806 center-based clusters. Evaluation of a sample of the
clusters by MTurk resulted in a mean score 4.331 ± 0.796 on a scale of 1–5 (5 indicating ‘‘strongly agree
that the trials in the cluster are similar’’).
Conclusions: We contribute an automated approach to clustering clinical trials with similar eligibility fea-
tures. This approach can be potentially useful for investigating knowledge reuse patterns in clinical trial
eligibility criteria designs and for improving clinical trial recruitment. We also contribute an effective
crowdsourcing method for evaluating informatics interventions.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The past few decades have witnessed heightened expectations
for transparency in scientiﬁc research. Vast troves of clinical and
research data have been digitized and made publicly available by
governmental agencies, corporations, and private organizations.
The availability of these data has generated a great need for
innovative methods that leverage such Big Data to improve
healthcare delivery and to accelerate clinical research [1].
However, gaining meaningful insights from this Big Data is fraught
with challenges.
For example, in one of the largest clinical trial repositories,
ClinicalTrials.gov1, there are more than 145,745 clinical trials as of
May 2013. Information overload is an unsolved problem when
searching for relevant clinical trials in this repository. Methods havebeen developed to address this problem [2–8], such as web-based
EmergingMed2, SearchClinicalTrials.org3, and the UK Clinical Trials
Gateway4, and mobile device-based NCITrials@NIH5, ClinicalTrials
Mobile6, and ClinicalTrials.app7. Although these methods are helpful
in narrowing the search for trials, they require users to come up with
effective queries, which can be a difﬁcult task given the complexity
of eligibility criteria [9] and of medical terminologies.
One alternative to clinical trial search based on a user query is
case-based search, which identiﬁes trials similar to an example
trial. Such an approach can remove the burden for query formula-
tion from the user and is deemed to be useful in multiple usage
scenarios. For clinical trial volunteers, a trial for which they qualify
but cannot join due to closed enrollment, geographic distance from
the recruitment site, or other practical reasons, can serve as a
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clinical trial investigators, case-based search might help identify
colleagues recruiting similar patients for related diseases and in-
form the eligibility criteria design of a new trial. For meta-analysis
researchers, this method can identify studies with similar eligibil-
ity features and help uncover knowledge reuse patterns among
related studies or improve the efﬁciency of systematic reviews.
To support the aforementioned use cases, in this paper we pres-
ent an automated approach to identifying clinical trials with simi-
lar eligibility criteria, across and within diseases, based on the
similarity in semantic eligibility features. In the context here, a
semantic feature is a clinically meaningful patient characteristic,
such as a demographic characteristic, a symptom, a medication,
or a diagnostic procedure, used to determine a volunteer’s eligibil-
ity for a trial. It contains either one word, (e.g., ‘‘cardiomyopathy’’)
or multiple words (e.g., ‘‘biopsy-proven invasive breast carci-
noma’’) [8]. We focused on similarity measures at the concept level
because as noted by Korkontzelos et al. [10], decreasing the length
of lexical units, from sentences to phrases or tokens, can solve the
sparsity problem in identifying eligibility criteria that are impor-
tant for a particular study, though a potential tradeoff of this meth-
od is that unimportant functional words and phrases are more
frequent than meaningful ones in the biomedical domain.
An important premise of our proposed approach is that numer-
ical values in eligibility criteria, such as constants in expressions
for age and laboratory results, are not necessary considerations
for determining eligibility criteria similarity at the concept level.
For example, our method does not differentiate ‘‘Age: 50–65’’ from
‘‘Ages: 10–17’’, or differentiate ‘‘HbA1C > 6.5’’ from ‘‘HbA1C < 6.5’’.
For clinical trials with a small number of eligibility criteria fea-
tures, this limitation might result in incorrect clustering of trials
with semantically different eligibility criteria. However, eligibility
criteria are rich in features, with an average of 38.5 features per
trial on ClinicalTrials.gov. When two trials are deemed similar
using our method, a majority of eligibility features must match;
therefore, the differences in the attributes associated with any fea-
ture have minimal inﬂuence on overall trial similarity. In other
words, it is unlikely that a trial recruiting patients aged 50–65
would match a trial recruiting patients aged 10–17 in all other eli-
gibility features. The presence of many features helps our method
distinguish trials recruiting different target populations despite the
disregard for numerical values in any given feature.
The rest of this paper is organized as follows. We ﬁrst describe
our processes for semantic feature extraction and trial clustering
based on feature similarities. Then we introduce a crowdsourcing
method for evaluating the similarities of the resulting clusters
using Amazon’s Mechanical Turk. On this basis, we present the per-
formance metrics for this method.2. Materials and methods
Fig. 1 illustrates the methodology framework. We obtained the
free-text eligibility criteria for all registered trials (N = 145,745 as
of September 2013) listed on ClinicalTrials.gov. We then used the
Uniﬁed Medical Language System (UMLS) Metathesaurus to recog-
nize all biomedical concepts, which serve as the semantic features,
and assigned a suitable UMLS semantic type for each of them. On
this basis, we constructed a trial-feature matrix to cluster trials
using pairwise similarity. Our design rationale and implementation
details are further provided below.8 https://gist.github.com/alexbowe/879414.2.1. Extracting semantic features
Although UMLS’s parser, MetaMap, is the mostly widely used
parser for biomedical concept recognition, we chose to developour own concept recognition algorithm to avoid the limitations
in MetaMap output as identiﬁed by Luo et al. [11]. For example,
the criterion ‘‘Patients with complications such as serious cardiac,
renal and hepatic disorders’’ was parsed by MetaMap Transfer
(MMTx) as {Patients |Patient or Disabled Group} {with complica-
tions |Pathologic Function} {such as serious cardiac, renal |Idea or
Concept} {and|} {hepatic disorders |Disease or Syndrome}. These
results were not granular enough. Additionally, MMTx returned
the phrase ‘‘such as serious cardiac, renal’’ as a single constituent,
which was problematic.
Excluding trials with no or non-informative text, such as
‘‘please contact site for information’’ (e.g., NCT00000221), for each
remaining trial listed on ClinicalTrials.gov, we extracted its eligibil-
ity criteria text and preprocessed it by removing white spaces. We
then performed sentence boundary detection for feature extrac-
tion. We ﬁrst tried commonly used sentence boundary detectors
such as the NLTK sent_tokenize function [12] but they alone were
ineffective due to the variability in the formatting of the criteria
text, e.g., some sentences lacked boundary identiﬁers or used dif-
ferent bullet symbols as separators. Therefore, we ﬁrst applied bul-
let symbols or numbers as splitting identiﬁers and then applied
NLTK on the remaining text chunks. For example, the eligibility cri-
teria text of trial NCT00401219 contained both bullet symbols and
a sentence boundary identiﬁer. Therefore, the text was ﬁrst split
using the bullet symbols and then chunked using the identiﬁers.
We improved the NLTK function to handle words like ‘‘e.g.’’ and
‘‘etc.’’, which were incorrectly separated by the period symbol.
We identiﬁed terms using a syntactic-tree analysis after
part-of-speech (POS) tagging. This method was better than an
n-gram-based method for pair-wise similarity calculation because
the latter generated overlapping terms, which could lead to overes-
timation of similarity, or omitted candidate features that were not
sufﬁciently frequent, which could cause underestimation of simi-
larity. After testing several parsers, we utilized an open library8
to generate syntactic trees based on POS tags labeled by NLTK. Using
predeﬁned parsing rules, we traversed the syntactic trees and ex-
tracted phrases using NLTK WordNet lemmatizer and stemming
modules. For example, from the sentence ‘‘a multi-center study of
the validity’’ the algorithm would generate the following syntactic
tree: {(S a/DT (NP (NBAR multi-/NN center/NN study/NN)) of/IN
the/DT (NP (NBAR validity/NN)))}. From the tree, two noun phrases
were extracted using NBAR tag (one predeﬁned rule): ‘‘multi-center
study’’ and ‘‘validity’’.
Being candidate semantic features, all terms were looked up in
the UMLS using normalized substring matching rather than exact
string matching. The advantage of this fuzzy term mapping strat-
egy is that partial or complete term could be mapped to a UMLS
concept. For example, we can extract a semantic feature ‘‘serious
hypertensive disease’’, where ‘‘hypertensive disease’’ is a UMLS
concept, from term ‘‘serious systemic arterial hypertension’’ even
if the latter as a whole does not exist in UMLS. For a term p, each
word w was assigned as a start point for substring generation after
checking with a list of English stop words, a list of non-preferred
POS tags, and a list of non-preferred semantic types. For a start
pointwi, substring fromwi to an end point wordwj (i < j < length(p),
wj e p) was generated as sij with j from reverse direction (largest
substring ﬁrst). sij was then processed through UTF decoding, word
normalization (by NLTKWordNet Lemmatizer and word case mod-
iﬁer), word checking (on punctuations, numeric, English stop
words, and medical related stop words), and acronym checking
to match with UMLS concepts. If there was no match, it moved
to substring si(j1) for next matching until j = i + 1. Once there
was a match, the start point wi was set to point wj (skip the start
Fig. 1. The framework for automatically identifying clinical trial clusters based on eligibility criteria similarity.
9 https://www.mturk.com/.
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round of matching until i equals length(p)  1.
A term can be associated with multiple UMLS concepts with dif-
ferent semantic types. We performed concept disambiguation
using a set of predeﬁned semantic preference rules [13]. For exam-
ple, a term ‘‘pregnancy test negative’’ was associated with two
UMLS concepts, one being ‘‘pregnancy test negative’’ of the seman-
tic type ‘‘Laboratory or Test Result’’ and the other being ‘‘reported
negative home pregnancy test’’ of the semantic type ‘‘Finding’’. In
the UMLS Semantic Network, ‘‘Laboratory or Test Result’’ is a sub-
type of ‘‘Finding’’. Hence, the more speciﬁc concept ‘‘pregnancy test
negative’’ was assigned to this term.
We did not distinguish between inclusion and exclusion criteria
for semantic feature extraction because not all trials, such as trial
NCT00000114, had separate inclusion and exclusion criteria sec-
tions. The extracted unique semantic features were used for gener-
ating a trial-feature matrix and for calculating trial similarity. In
the trial-feature matrix, each row corresponds to a set of semantic
features from a certain trial and each column shows a certain fea-
ture existing in different trials. If a trial ti contains semantic feature
sfm, row i and column m was recorded as 1, otherwise as 0.
2.2. Determining pairwise similarity
There are plenty of measures of semantic similarity between
concepts used in Natural Language Processing [14–18]. Pedersen
et al. [19] presented the adaptation of six domain-independent
measures and showed that an ontology-independent measure
was most effective. Particularly for text clustering, Huang [20]
compared 5 widely used similarity measures on 7 datasets and
showed that the Jaccard similarity coefﬁcient achieved best score
on a well-studied dataset containing scientiﬁc papers from four
sources. We adopted the Jaccard similarity coefﬁcient for calculat-
ing pairwise similarity as it can assess both similarity and diversity
[21]. For a collection of trials T = {t1, ti, . . . tj, . . . tk} containing k trials,
the pairwise similarity Simi of any two trials ti and tj was calculated
as follows:
Simiðti; tjÞ ¼
0; jSFðtiÞ jorj SFðtjÞj ¼ 0
jSFðtiÞ \ SFðtjÞj
jSFðtiÞ [ SFðtjÞj ; otherwise
(
SF(ti) and SF(tj) are two sets of semantic features corresponding to ti
and ti, respectively. If either SF(ti) or SF(tj) contains no semantic fea-
tures, then the similarity is recorded as 0. Otherwise, it is calculated
as the number of shared features (SF(ti) \ SF(tj)) divided by the
number of features in the union (SF(ti) [ SF(tj)).Due to the large number of trials and the large volume of
semantic features, calculating the similarity between every possi-
ble pair of trials would be computationally intensive. To improve
efﬁciency, we ﬁrst ranked all trials by their counts of semantic fea-
tures. Trial pairs with a large difference in their feature counts
were discarded, since the large count gap would lead to a low sim-
ilarity as the shared features were too few compared to the union
features. We deﬁned two rules to select similar trial pairs:
|SF(ti)| > 2*|SF(tj)| and |SF(ti)| < |SF(tj)|/2, indicating that trial pairs
with similarity below 0.5 were considered to have unsatisfactory
similarity and discarded.
2.3. Clustering trials
There are many clustering models based on connectivity, cen-
troid, distribution, and so on [22–26]. Methods such as K-means
and hierarchical clustering were also assessed. Inspired by the
known algorithm Nearest Neighbor Search (NNS) [27], for each un-
ique trial, we constructed a cluster by using this trial as the center
and by identifying all its near neighbors. To measure nearness, we
calculated the distance between each neighbor and the central trial
using the following formula: distance = 1-similarity, where the
similarity was the previously calculated pairwise similarity be-
tween the trial pair. For any central trial x, only trials whose simi-
larities to the trial were greater than or equal to a predeﬁned
similarity threshold d were included in the cluster centered on x.
Therefore, we refer to these clusters as center-based clusters. Con-
nected center-based clusters were merged to form similarity-based
clinical trial network using the DBScan algorithm [28]. In order to
facilitate visualization and statistical analyses of clusters, we re-
moved structural information (i.e., center vs. neighbor) and identi-
ﬁed trial sets with distinctive membership compositions from all
center-based clusters and named these sets as unique clusters.
Fig. 2 illustrates the center-based and unique clusters for example
trials.
2.4. Evaluation design
The Amazon Mechanical Turk (MTurk9) is an online crowdsourc-
ing platform that enables human workers to perform human intelli-
gence task (HIT) [29]. It has been shown to be effective for similarity
evaluation. For example, Snow et al. [30] reported high agreement
between MTurk non-expert annotations and existing gold standards
Fig. 2. Center-based clusters and unique clusters constructed from four example trials.
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similarity evaluation task. MTurk has also been used for evaluating
biomedical informatics research. For instance, Maclean and Heer
[31] presented crowdsourcing patient-authored text medical word
identiﬁcation tasks to MTurk non-experts and achieved results that
were comparable in quality to those achieved by medical experts.
Therefore, we used MTurk for evaluating the similarity within our
clusters.
Regarding the limitations of using MTurk, Mason and Suri [32]
pointed out some of these in their systematic review of MTurk withFig. 3. The user interface of HIT designerespect to efﬁciency improvement, quality assurance, security, eth-
ics and privacy. They also suggested possible techniques to control
submission quality, which were partially applied in our evaluation.
Lee [33] summarized the 9 beneﬁts and 4 limitations of using
MTurk, including ‘‘instructions needed clariﬁcation over several
tests’’. Following these suggestions, we designed a two-phase eval-
uation and deﬁned answer rejection rules to ensure data quality
from MTurk. In the ﬁrst phase, we determined the optimal similar-
ity threshold. In the second phase, we evaluated the clusters
generated using the optimal threshold.d for MTurks for cluster evaluation.
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Based on empirical results we selected three candidate thresh-
olds for optimization: i.e., 0.7, 0.8 and 0.9. We generated trial pairs
having a similarity equal to each threshold. To obtain a representa-
tive sample, we plotted the distribution of average word counts per
pair of texts as a box-plot. We then selected a total of 20 pairs of
texts, 5 from each quartile, from this distribution curve for each
of the three thresholds. In total we generated 60 pairs of texts
for evaluation.
The evaluation set was published as a HIT on the MTurk website
with a reward of $1.20 offered for completion of the entire HIT. For
each pair of texts, workers were asked whether they agreed with
the statement ‘‘The texts in the pair are similar.’’ Workers were in-
structed to avoid differences in actual numbers (e.g., age, cutoffs
for laboratory values, etc.) and to focus only on broad criteria con-
cepts when calculating similarity. Available answer choices were
‘‘Strongly agree’’, ‘‘Agree’’, ‘‘Neither agree nor disagree’’, ‘‘Disagree’’,
and ‘‘Strongly disagree’’. To quantify the mean and standard devi-
ation (SD) of the answers for each candidate threshold, we mapped
each of the above choices to numbers 5, 4, 3, 2, and 1, respectively.
The optimal similarity threshold was selected by comparing the
means and SDs of the three candidate thresholds.
To assure that workers were paying attention and not just ran-
domly selecting answers, and to ﬁlter out ‘‘spammers’’ or ‘‘bots’’
[32], we inserted the hidden phrase ‘‘Waldo is hiding here’’ into
one of the comparison text pairs. In the instructions, workers were
informed that this phrase would appear in some of their eligibility
criteria texts. They were instructed to select the answer choice
‘‘Found Waldo’’ upon seeing the phrase in the text rather than
any of the choices pertaining to similarity. The instructions also ex-
plained that workers who failed to discriminate between pairs
with or without the hidden phrase would result in rejection, with-
out payment, of their work and a negative review of their perfor-
mance posted to their proﬁle. The entire HIT for any worker who
failed the hidden phrase identiﬁcation was deemed invalid and ex-
cluded. We continued recruiting workers until we got a total of 10Fig. 4. The eligibility criteria of trials in an exavalid, completed HITs. This resulted in 10 evaluations by unique
workers of the entire 60-pair set.
2.4.2. Phase II – cluster evaluation
Using the optimal threshold from Phase I, we generated unique
clusters. To ensure a fair sampling of cluster sizes, the distribution
of cluster sizes, measured in the number of nodes, was presented
as a box plot. An evaluation set of 40 clusters, 10 selected from
each quartile, was then generated. The evaluation set was
published as a HIT on the MTurk website with a reward of $1.20
offered for completion of the entire HIT. For each cluster, workers
were asked to rate if every cluster contained similar texts using a
5-Likert scale. As in Phase I, workers were instructed to ignore
the differences in attribute values, e.g., age, cutoffs for laboratory
values, and to focus only on inclusion eligibility concepts when
determining similarity for each trial pair.
The user interface design for the HIT is shown in Fig. 3. Clicking
‘‘click to view cluster’’ opens a page (Fig. 4) containing eligibility
criteria texts from ClinicalTrials.gov for comparison.
We employed the same hidden phrase identiﬁcation method for
quality control as described in Phase I. Additionally, by performing
the HIT ourselves, we estimated that it would be difﬁcult to per-
form an accurate assessment of 40 clusters in less than 20 min.
Accordingly we excluded the entire HIT if it was completed in less
than 20 min. We continued recruiting workers until we got a total
of 20 (double the number in Phase I) valid and complete HITs. This
resulted in 20 evaluations by unique workers for the entire 40 clus-
ter set.
3. Results
3.1. Semantic features and clusters
We extracted all 145,745 clinical trials present on ClinicalTrials.
gov as of 05/17/2013. After excluding the trials whose eligibility
criteria text section were missing or contained only the phrasemple cluster for comparison by workers.
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used as our dataset. We identiﬁed 2,770,746 sentences, fromwhich
5,508,491 semantic features (459,936 unique) were extracted, with
38.5 features per trial on average. Of the unique features, 160,951
(34.99%) were shared by at least two trials. For instance, Table 1
aligns part of the semantic features extracted from trials
‘‘NCT00822978’’ and ‘‘NCT01034774’’. The two trials shared 30 fea-
tures (marked as ‘‘Y’’ in ‘‘Shared’’ column) and had 3 different fea-
tures: ‘‘iodine’’, ‘‘excessive alcohol consumption’’, and ‘‘illegal
substance’’. As a result, their pairwise similarity is 0.91.
The percentage of unique features that are shared by at least
two trials varies by the total number of trials used for feature
extraction, as shown in Fig 5. With a sample of 40,000 trials, the
percentage of shared features is 31.34%. Beyond this point, increas-
ing the number of trials only slightly affects this percentage. In our
dataset, 34.99% of unique features are shared across all trials.
Therefore, these shared features could be used to aid standardiza-
tion efforts for clinical trials eligibility criteria. The remaining
65.01% of features are unique to a given trial. These features could
be useful for distinguishing trials but not useful for clustering sim-
ilar trials.
After discarding trial pairs with similarity less than 0.5, a total
of 386,992 pairs remained and were used for clustering. Using
the optimal similarity threshold (d = 0.9), as determined by the
MTurk evaluation, 8806 center-based and 3,614 unique clusters
were generated. Cluster sizes ranged from 2 to 734 members.
Table 2 shows the statistics for the ﬁrst 9 sizes (2–10). Of the cen-
ter-based clusters, most contained 2 (5680 clusters, 64.5%) or 3
(969 clusters, 11.0%) trials. Overall, the average center-based clus-
ter size and unique cluster size are 65.34 and 2.85, respectively.
There were 2157 (24.5%) center-based clusters and 314 unique
clusters (8.69%) containing more than 3 trials, with the largest
cluster containing 734 trials.3.2. Evaluation results using MTurk
In Phase I of the MTurk based evaluation, 20 pairs of eligibility
criteria texts were selected from each of three similarity thresh-
olds: 0.7, 0.8, and 0.9. Distributions of text length (measured as
average number words per pair) for each threshold (Table 3) were
used to select a representative sample of text lengths. Five pairs of
texts were randomly selected from each quartile range. For exam-
ple, for threshold of 0.7, the minimum, 1st quartile, median, 3rd
quartile, and maximum are 26, 69, 108, 294.5, and 845, respec-
tively, with the corresponding ranges being 26–69, 69–108,Table 1
Parts of semantic features extracted from trials NCT00822978 and NCT01034774.
NCT00822978 NCT01034774 Shared
Hypertensive disease Hypertensive disease Y
Deafness Deafness Y
SGCG gene SGCG gene Y
Kidney problem Kidney problem Y
Hearing Hearing Y
Aminoglycosides Aminoglycosides Y
Family history Family history Y
Seizures Seizures Y
Asthma Asthma Y
Recent blood donor Recent blood donor Y
Ear structure Ear structure Y
Previous injury Previous injury Y
Diabetes Diabetes Y
Continue medical condition Continue medical condition Y
Smoker Smoker Y
Heart diseases Heart diseases Y
Iodine Excessive alcohol consumption N
Illegal substance N108–294.5, 294.5–845. As a result, a total of 20 pairs of texts for
the threshold were selected. Of note, even though it appears that
there is a correlation between threshold and text length based on
the three thresholds presented here, such a correlation was not
observed on a bigger dataset of ten thresholds and their corre-
sponding mean text lengths.
Of the 13 submissions received from 13 unique workers, three
were rejected because the workers failed to identify the text con-
taining ‘‘waldo’’. We accepted the remaining 10 submissions for a
total expense of $13.20 ($1.20/submission x 10 submis-
sions + $1.20 commission fee). The mean and standard deviation
(SD) of the scores for each threshold are shown in Table 4. The
average of mean and standard deviation for all the thresholds are
3.72 and 1.08, respectively. We selected 0.9 as the optimum simi-
larity threshold because this was the only threshold where the
mean score was >4, which corresponds to the ‘‘Agree’’ choice.
In the Phase II of the evaluation, 20 unique workers evaluated
40 unique clusters. Ten clusters were randomly selected from each
quartile range of the distribution of cluster sizes (measured as the
number of trials in the cluster). The minimum, 1st quartile, median,
3rd quartile, and maximum cluster sizes were 2, 2, 2, 2, and 734,
respectively. A total of 23 submissions were received, 20 of which
were accepted. Three submissions were rejected either for failing
to identify the text containing ‘‘waldo’’ or for completing the eval-
uation too quickly, a sign of lack of careful consideration. The aver-
age time spent by workers on this task was 29 min.
One of the accepted submissions was originally rejected due to
failure to correctly identify the text containing ‘‘waldo’’ but, after
review by the authors, was later accepted after this worker ex-
plained that he tried but failed to ﬁnd the ‘‘waldo’’ text. As for
the evaluation, the total cost for Phase II was $24 (=$1.20/submis-
sion x 20 submissions + $2.40 commission). The inter-rater reli-
ability was calculated as 0.92, using Cronbach’s Alpha10. The
mean cluster quality score was 4.331 ± 0.796; i.e., the overall re-
sponse to the statement ‘‘This is a good cluster’’ was between
‘‘Agree’’ (4) and ‘‘Strongly agree’’ (5).
3.3. Disease-speciﬁc network visualization
Our method can visualize results as trial networks. For example,
by limiting our dataset to ‘‘Breast Cancer’’, we extracted 5309 trials
present on ClinicalTrials.gov as of 05/20/2013. A total of 4844 trials
were obtained after initial eligibility criteria ﬁltering and 117,388
sentences were acquired after sentence boundary identiﬁcation.
From these, we extracted 255,614 semantic features and 98 cen-
ter-based clusters (2.55 trials per cluster on average) using a sim-
ilarity threshold of 0.9. A network diagram containing the clusters
and unique features was automatically generated for visualization
of the relatedness of the clusters (Fig. 6). The large orange nodes
represent individual clinical trials, while small blue nodes repre-
sent unique semantic features. The links between one feature node
and multiple trial nodes denote that the semantic feature is shared
by the trials. The more semantic features shared by trials, the clo-
ser are the trials. For a semantic feature, the more trials it is con-
nected to, the closer it is located in to the center of the network
(i.e., the high density area).
3.4. A cluster-based clinical trial search interface
We used the similarity-based search to enhance the ClinicalTri-
als.gov search interface for clinical trials. A demonstration system
for this design is available online11. After searching for trials using10 http://en.wikipedia.org/wiki/Cronbach’s_alpha.
11 http://columbiaelixr.appspot.com/cluster.
Fig. 5. Percentage of unique features shared by at least two trials as a function of total number of trials.
Table 2
The relationship between cluster size and number of clusters.
Cluster size Number of clusters
Center-based Unique
2 5680 (64.5%) 2910 (80.5%)
3 969 (11%) 390 (10.8%)
4 464 (5.3%) 146 (4%)
5 222 (2.5%) 61 (1.7%)
6 78 (0.9%) 22 (0.6%)
7 79 (0.9%) 16 (0.4%)
8 20 (0.2%) 6 (0.2%)
9 53 (0.6%) 13 (0.4%)
10 50 (0.6%) 11 (0.3%)
Table 3
The quartile distribution of eligibility criteria text length measured by the average
number of words per trial pair.
d Min 1st Quart. Median 3rd Quart. Max Mean
0.7 26 69.00 108.00 294.50 845 220.50
0.8 15 54.50 96.75 272.60 959 205.20
0.9 34 43.00 43.00 65.25 909 80.43
Table 4
The mean and standard deviation of MTurk similarity ratings at different thresholds.
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trial to perform a cluster-based search and view trials with similar
eligibility criteria features. Adjacent to each trial in the cluster was
an indicator showing whether this trial belonged to another cluster.
A user could choose to view that cluster. In this way, users would be
able to explore the network of trials, whose eligibility criteria were
similar to the initial trial of interest.4. Discussion
We presented a method for clustering trials with similar eligi-
bility criteria features to facilitate case-based clinical trial search.
Nearly 35% of the features we extracted are shared by at least
two trials. Our approach produced clusters of manageable sizes.
Though more than 85% of the center-based clusters containedbetween 2 and 7 trials, the mean cluster size was 65.34. This effect
is mostly due to the presence of one large 734-member cluster. A
closer look at the individual trials comprising this cluster revealed
that all trials had identical eligibility criteria texts comprised of
only one sentence: ‘‘No eligibility criteria’’. Further analysis re-
vealed that the eligibility criteria for these trials tended to be con-
tained in other sections of the trial description. For some of these
trials, diseases listed in the ‘‘Conditions’’ section (NCT00005154)
were the only identiﬁable eligibility criteria. Since search by condi-
tion (a list of standardized elements) is already a search function of
ClinicalTrials.gov, we did not include the condition section in our
analysis of trial similarities. For a few trials, eligibility criteria were
contained in the ‘‘Detailed Description’’ section (NCT00005444).
This, combined with the presence of vast amounts of text pertain-
ing to aspects of the study unrelated to eligibility contained within
the ‘‘Detailed description’’ section, prompted us to exclude this
section in our analysis. Finally, some trials contained no speciﬁc
eligibility criteria anywhere in the trial description but did contain
some general requirements, such as age and gender
(NCT00005721). Since speciﬁc criteria are required to distinguish
trials, we chose to exclude these trials for analysis.
Most clusters were either 2-member (64.5%) or 3-member
(11%) clusters due to the use of a high similarity threshold (0.9).
The MTurk workers lacked biomedical domain knowledge, which
could potentially explain their preference for literal similarity with
such a high threshold, though the advantage is that there was a
high inter-rater reliability.
4.1. Limitations and future work
A recent publication showed that the trial summaries on Clini-
calTrials.gov were more condensed than full-text protocols for 32
studies [34]. Therefore, similarity results based on the eligibility
criteria text on ClinicalTrials.gov may not hold when full-text clin-
ical protocols are used for all studies. However, our approach can
be applied to assess protocol similarity. Since full-text clinical-trial
protocols are usually not freely available (especially for ongoing
studies), the current use of ClinicalTrials.gov as the data source is
the best solution available at present.
The clusters we generated were meaningful and contained
highly similar trials, which is the counterpart to high precision in
information retrieval, but we may not have identiﬁed all such clus-
ters, which is the counterpart to low recall in information retrieval.
Recall may be improved by lowering the similarity threshold,
which could decrease the proportion of 2- and 3-member clusters
and increase the proportion of larger clusters, decreasing the de-
gree of positive skew of cluster sizes. However, this improvement
Fig. 6. The dynamically generated network diagram of all ‘‘Breast Cancer’’ related trials (http://columbiaelixr.appspot.com/static/cluster_breast_cancer.html).
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clusters at the lower thresholds would not be as relevant with
member trials not as similar to each other). Therefore, one must
balance the tradeoff between precision and recall by optimizing
similarity threshold determination. Our use of MTurk for threshold
optimization proved to be effective, though our starting range in-
cluded only three thresholds derived through empiric testing and
we used a small subset of eligibility criteria texts. More candidate
thresholds and larger amounts of eligibility criteria text could be
used for threshold optimization.
Our methodology does not take into account the attributes of
eligibility features, such as the numerical value ranges for quanti-
tative features, e.g., Age > 75 years old. As discussed in the Methods
section, the effect of this disregard for numerical data is minimized
by the presence of a large number of features (i.e., an average of
38.5) per trial, which, when considered together, help distinguish
trials with different target populations. Yet our method may still
mistakenly cluster trials recruiting different populations together
due to this limitation. Thus, eligibility for one trial in a cluster does
not necessarily imply qualiﬁcation for all trials in the cluster. We
are working on a method for extracting and utilizing information
from numerical values ranges to further improve trial similarity
measures in the future.
As the increase of the similarity threshold tends to decrease the
proportion of larger clusters, high thresholds may be too restrictive
for some users by displaying too few highly trials that are similar
to the center one. One solution to this problem is to optimize
threshold determination. Another approach is to rank trials by
their similarity scores and to pick relative higher ones in each clus-
ter. We intend to assess the utility of these methods in the future.
Network visualization enables a global view of a similarity-
based clinical trial network that can show how trials are connected
by common medical concepts and how these concepts are shared
by different trials, across or within diseases. Another future work
idea is to combine similarity-based trial networks with other net-
works such as those based on geographic locations for helping elu-
cidate relationships among clinical trials from multiple
perspectives.5. Conclusions
We developed an automated approach for clustering trials of
similar eligibility criteria. Our evaluation conﬁrmed the similarities
within clinical trial clusters, which can be valuable for researchers
and patients alike. Our experience with the Amazon Mechanical
Turk conﬁrmed that with careful data quality control, crowdsourc-
ing was an effective approach to engage the public to participate in
evaluations of biomedical informatics interventions. We hope our
clinical trial search method can be integrated into clinical trial
search engines to make clinical trial search easier for end users.Author contributions
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